Folate, homocysteine, and negative symptoms in schizophrenia
J., Lamberts, L., Ostman, E., Bjorck, I
doi: 10.3389/fphar.2022.808855 Received 04 November 2021 Accepted 11 February 2022 Published 17 March 2022 Volume 13 - 2022 Edited by Leo A van Grunsven, Vrije University Brussel, Belgium Reviewed by Prasanna K
NOTCH1 promotes T cell leukemia-initiating activity by RUNX-mediated regulation of PKC-theta and reactive oxygen species
Abstract Glucagon-like peptide 1 (GLP-1)-based therapies, such as semaglutide and tirzepatide, represent highly effective treatment options for people with type 2 diabetes and obesity, enabling effective control of glucose and weight loss, while reducing cardiovascular and renal morbidity and mortality
M.GhateiM